tirzepatide surpass-4 Effects of versus insulin glargine on kidney outcomes in type 2 diabetes in the trial: post-hoc analysis of an open-label, randomised, phase 3 trial Read now: The SURPASS-EARLY trial
Pay in 4 interest-free payments of $5.61 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3

























